Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA gyrase and topoisomerase IV are type II topoisomerases found in bacteria, essential for managing DNA topology during replication and cell division. DNA gyrase introduces negative supercoils and removes positive supercoils ahead of the replication fork. Topoisomerase IV decatenates interlinked daughter chromosomes and relaxes positive supercoils behind the replication fork. Both enzymes are heterotetramers and are targeted by quinolone antibiotics.
Quinolones trap enzyme-DNA cleavage complexes, inhibiting DNA synthesis and leading to cell death.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Gyrase/Topoisomerase IV (Bacterial) (N/A).